How to buy Alterity Therapeutics (ATHE) shares in the UK

Learn how to easily invest in Alterity Therapeutics shares.

Alterity Therapeutics Limited (ATHE) is a leading biotechnology business based in the US. It opened the day at $1.36 after a previous close of $1.36. During the day the price has varied from a low of $1.3201 to a high of $1.38. The latest price was $1.37 (25 minute delay). Alterity Therapeutics is listed on the NASDAQ and employs 11 staff. All prices are listed in US Dollars.

How to buy shares in Alterity Therapeutics

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: ATHE in this case.
  5. Research Alterity Therapeutics shares. The platform should provide the latest information available.
  6. Buy your Alterity Therapeutics shares. It's that simple.
The whole process can take as little as 15 minutes.

How has coronavirus impacted Alterity Therapeutics's share price?

Since the stock market crash that started in February 2020, Alterity Therapeutics's share price has had significant positive movement.

Its last market close was $1.28, which is 42.98% up on its pre-crash value of $0.7299 and 357.14% up on the lowest point reached during the March 2020 crash when the shares fell as low as $0.28.

If you had bought $1,000 worth of Alterity Therapeutics shares at the start of February 2020, those shares would have been worth $888.89 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,580.25.

Alterity Therapeutics share price (NASDAQ:ATHE)

Use our graph to track the performance of ATHE stocks over time.

Alterity Therapeutics shares at a glance

Information last updated 2021-06-28.
Open$1.36
High$1.38
Low$1.3201
Close$1.37
Previous close$1.36
Change$0.01
Change %0.7353%
Volume191,528
Information last updated 2021-09-26.
52-week range$1.09 - $2.48
50-day moving average$1.3324
200-day moving average$1.3963
Wall St. target price$4
Dividend yieldN/A (0%)
Earnings per share (TTM)$-0.42
Promoted
eToro Free Stocks

Invest in Alterity Therapeutics shares with 0% commission

Other fees apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • Pay no stamp duty on UK shares (saving 0.5%)
  • Create an account today in a few minutes
Capital at risk

Fees for buying 200x Alterity Therapeutics shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
Freetrade logo £0 No minimum £0.90
£201.58 total
Capital at risk
eToro Free Stocks logo £0 $50 £1.00
£201.68 total
Capital at risk
Fineco logo £0 No minimum £2.01
£202.68 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £1.22
£201.89 total
Capital at risk
Stake logo £0 £50 £1.59
£202.27 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £14.54
£215.22 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £11.59
£212.26 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £12.59
£213.27 total
Capital at risk

Full comparison of share dealing platforms

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is it a good time to buy Alterity Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Alterity Therapeutics price performance over time

Historical closes compared with the last close of $1.37

1 week (2021-09-21) 6.20%
1 month (2021-08-27) -1.44%
3 months (2021-06-28) 1.37
6 months (2021-03-26) -6.16%
1 year (2020-09-28) -33.82%
2 years (2019-09-27) 15.13%
3 years (2018-09-28) -31.84%
5 years (2016-09-28) -71.40%

Financials

Revenue TTM $4.3 million
Gross profit TTM $4 million
Return on assets TTM -46.5%
Return on equity TTM -81.39%
Profit margin 0%
Book value $0.9
Market capitalisation $53.6 million

TTM: trailing 12 months

How to short and sell Alterity Therapeutics shares

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "ATHE.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 851,629 Alterity Therapeutics shares held short by investors – that's known as the "short interest". This figure is 1.1% up from 842,056 last month.

There are a few different ways that this level of interest in shorting Alterity Therapeutics shares can be evaluated.

Short interest ratio (SIR)

Alterity Therapeutics's "short interest ratio" (SIR) is the quantity of Alterity Therapeutics shares currently shorted divided by the average quantity of Alterity Therapeutics shares traded daily (recently around 3.4 million). Alterity Therapeutics's SIR currently stands at 0.25. In other words for every 100,000 Alterity Therapeutics shares traded daily on the market, roughly 250 shares are currently held short.

However Alterity Therapeutics's short interest can also be evaluated against the total number of Alterity Therapeutics shares, or, against the total number of tradable Alterity Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Alterity Therapeutics's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Alterity Therapeutics shares in existence, roughly 20 shares are currently held short) or 0.0254% of the tradable shares (for every 100,000 tradable Alterity Therapeutics shares, roughly 25 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Alterity Therapeutics.

Find out more about how you can short Alterity Therapeutics stock.

Alterity Therapeutics share dividends

We're not expecting Alterity Therapeutics to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

Have Alterity Therapeutics's shares ever split?

Alterity Therapeutics's shares were split on a 1:6 basis on 24 March 2016. So if you had owned 6 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Alterity Therapeutics shares – just the quantity. However, indirectly, the new 500% higher share price could have impacted the market appetite for Alterity Therapeutics shares which in turn could have impacted Alterity Therapeutics's share price.

Share price volatility

Over the last 12 months, Alterity Therapeutics's shares have ranged in value from as little as $1.09 up to $2.48. A popular way to gauge a stock's volatility is its "beta".

ATHE.US volatility(beta: 1.1)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Alterity Therapeutics's is 1.1003. This would suggest that Alterity Therapeutics's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Win £500 to get your trading started

Subscribe to trending stock alerts for a chance to win

By submitting, you agree to the Finder Privacy and Cookies Policy and Terms of Use

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked
Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site